Page 28 - The DHEA Debate - Life Extensions Magazine
P. 28
157. Strous RD, Maayan R, Lapidus R, et al. Dehydroepiandrosterone augmentation in the
management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen
Psychiatry. 2003 Feb;60(2):133- 41.
158. Office of Technology Assessment, US Congress. Assessing the Efficacy and Safety of
Medical Technologies. Washington, DC: Office of Technology Assessment, US Congress; 1978.
159. Jia Q, Hong MF, Cherniske S. Measurement and Quantification of 17 Ketosteroid-Sulfates
as a Biomarker of Biological Age. US patent 6,326,209 B1, Dec. 4, 2001.
160. Jia Q, Hong MF, Zhao XP, Orndorff S. Quantification of urine 17-ketosteroid sulfates and
glucuronides by high-performance liquid chromatography-ion trap mass spectroscopy. Journal
of Chromatography B, Biomed Sci Appl. 2001 Jan 5; 750(1):81-91.
161. Qi Jia, Mei-Feng Hong, Zhao-Xing Pan, et al. Quantification of urine 17-ketosteroid sulfates
and their age correlations. Spectroscopy. 2002;16:171-81.
